HAM
NVO

Harmony Asset Management’s Novo Nordisk NVO Stock Holding History

Harmony Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,900
Closed -$545K – 176
2025
Q2 		$545K Sell
7,900
-6,180
-44% -$420K 0.2% 105
2025
Q1 		$978K Sell
14,080
-47,697
-77% -$3.94M 0.41% 65
2024
Q4 		$5.31M Buy
61,777
+950
+2% +$103K 2.11% 8
2024
Q3 		$7.24M Hold
60,827
– – 2.66% 7
2024
Q2 		$8.68M Buy
60,827
+3,002
+5% +$398K 3.64% 6
2024
Q1 		$7.42M Sell
57,825
-800
-1% -$95.2K 3.06% 6
2023
Q4 		$6.06M Buy
+58,625
New +$5.8M 2.56% 7

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Harmony Asset Management's NVO Position: Q3 2025 in Review

Harmony Asset Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 7,900 shares — an estimated $545K sold.

Harmony Asset Management first reported a position in NVO in Q4 2023 and held it in 7 quarters. The position peaked at $8.68M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Harmony Asset Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Harmony Asset Management sold 7,900 Novo Nordisk shares in Q3 2025, an estimated $545K.
  • Harmony Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 7 quarters.
  • Harmony Asset Management's Novo Nordisk position peaked at $8.68M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Harmony Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.